KisoJi Biotechnology: Funding, Investors & Team (Aug 2026)
KisoJi Biotechnology is an early-stage biotechnology company developing antibodies for the treatment of various cancers. Unlike traditional industry methods, the full spectrum of antibody diversity can be identified and visualized, allowing for the pinpointing of clusters with desired characteristics and the optimization of lead candidate selection. The antibody platform includes multi-species single-domain antibody transgenic mice, AI-driven antibody fingerprinting to find the best fit with specific epitopes on any target, and a toolkit for creating robust, easily manufacturable multi-specific antibodies.
KisoJi Biotechnology has raised $40.6M across 1 funding round on record, the most recent a Series B of $40.6M announced in Dec 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
KisoJi Biotechnology Company Profile and Key Stats
Latest funding round on record: Dec 2024.
KisoJi Biotechnology Funding Rounds
KisoJi Biotechnology Founders and Leadership Team
No contact details are on record for this team yet.
KisoJi Biotechnology Funding Compared to Other Biotechnology Startups
KisoJi Biotechnology's latest round of $40.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like KisoJi Biotechnology in Biotechnology and Laval-ouest
Companies Similar to KisoJi Biotechnology
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
KisoJi Biotechnology Funding FAQs
What does KisoJi Biotechnology do?
KisoJi Biotechnology is an early-stage biotechnology company developing antibodies for the treatment of various cancers. Unlike traditional industry methods, the full spectrum of antibody diversity can be identified and visualized, allowing for the pinpointing of clusters with desired characteristics and the optimization of lead candidate selection. The antibody platform includes multi-species single-domain antibody transgenic mice, AI-driven antibody fingerprinting to find the best fit with specific epitopes on any target, and a toolkit for creating robust, easily manufacturable multi-specific antibodies.
How much funding has KisoJi Biotechnology raised?
KisoJi Biotechnology has raised $40.6M across 1 round on record. The most recent is a Series B of $40.6M announced in Dec 2024.
When did KisoJi Biotechnology last raise funding?
KisoJi Biotechnology's most recent funding round on record is a Series B of $40.6M, announced in Dec 2024.
Who founded KisoJi Biotechnology?
FundedIQ lists David Young (Founder) at KisoJi Biotechnology.
Where is KisoJi Biotechnology headquartered?
KisoJi Biotechnology is based in Laval-ouest, Quebec, Canada.
How many employees does KisoJi Biotechnology have?
KisoJi Biotechnology is in the 1-10 employee band.
How does KisoJi Biotechnology's funding compare to other Biotechnology startups?
KisoJi Biotechnology's latest round of $40.6M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's KisoJi Biotechnology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for KisoJi Biotechnology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.